8 completed, 1 recruiting. 9 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 9 | Completed 8, Recruiting 1 |
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow halofantrine: new trials by email Literature Review of halofantrine trials Research Report on halofantrine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy Individuals Recombinant herpes zoster vaccine with low-dose adjuvant, Recombinant herpes zoster vaccine with high-dose adjuvant, Low-dose adjuvant - Herpes Zoster (HZ) | Phase 1 / Phase 2 | Recruiting | Shanghai Institute Of Biological Products | 645 | 2025-04-04 | 2026-01-07 |
| Bioequivalence Trial of Alprazolam 0.25 mg Tablets Alprazolam 0.25 mg - Anxiety Disorders | Phase 1 | Completed | GlaxoSmithKline | 28 | 2010-12-02 | 2017-06-14 |
| Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs Cervarix, Placebo - Infections, Papillomavirus | Phase 1 | Completed | GlaxoSmithKline | 961 | 2007-10-17 | 2018-08-17 |
| A Relative Bioavailability Study of Bupropion HCI 150 mg Sustained-Release Tablets Under Fasting Conditions Bupropion HCI ER Tablets, 150 mg; EON Labs Inc., WELLBUTRIN SR (Bupropion HCI) Sustained-Release Tablets, 150 mg; GlaxoSmithKline - Depression | Phase 1 | Completed | Sandoz | 32 | 2005-09-01 | 2017-03-29 |
| Use of Sodium Stibogluconate as a Treatment for Leishmaniasis Sodium Stibogluconate (SSG) - Leishmaniasis | Phase 1 / Phase 2 | Completed | U.S. Army Medical Research and Development Command | 77 | 2004-10-01 | 2020-01-02 |
| To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Non-Fasting Conditions Ondansetron HCl 24 mg Tablets (Sandoz, Inc.), Zofran (Ondansetron HCl) 24 mg Tablets (GlaxoSmithKline) - Nausea, Vomiting | Phase 1 | Completed | Sandoz | 26 | 2004-09-01 | 2017-03-28 |
| To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Fasting Conditions Ondansetron HCl 24 mg Tablets (Sandoz, Inc.), Zofran (Ondansetron HCl) 24 mg Tablets (GlaxoSmithKline) - Nausea, Vomiting | Phase 1 | Completed | Sandoz | 26 | 2004-09-01 | 2017-03-28 |
| To Demonstrate the Relative Bioavailability of Bupropion HCI 300 mg Extended-Release Tablets Under Fasting Conditions Bupropion HCI 300 mg Extended-Release Tablets EON, WELLBUTRIN XL 300 mg Extended-Release Tablets GlaxoSmithKline - Depression | Phase 1 | Completed | Sandoz | 28 | 2004-03-01 | 2017-03-29 |
| Bioequivalency Study of Ranitidine Tablets 300 mg of Dr. Reddy's Under Fasting Conditions Ranitidine - Healthy | Phase 1 | Completed | Dr. Reddy's Laboratories Limited | 24 | 2003-01-01 | 2010-06-09 |
Depression (2) · Nausea (2) · Vomiting (2) · Anxiety Disorders (1) · Herpes Zoster (1) · Leishmaniasis (1) · Papillomavirus Infections (1) · Uterine Cervical Neoplasms (1) · Virus Diseases (1)
Sandoz (4) · GlaxoSmithKline (2) · Dr. Reddy's Laboratories Limited (1) · Shanghai Institute Of Biological Products (1) · U.S. Army Medical Research and Development Command (1)
Canada (2) · China (1) · Germany (1) · United States (1)
Soran Hong, M.D. (2) · Eric Bicrell, M.D. (1) · Roseanne Ressner, MD (1) · Shirley A Kennedy, M.D. (1) · So R Hong, M.D. (1) · Yeqing Tong (1)
PMID 24576907, PMID 24731816, PMID 26176261, PMID 30715452, PMID 41276263